| Title |
Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture
|
|---|---|
| Published in |
JAMA Internal Medicine, January 2007
|
| DOI | 10.1001/archinte.167.2.188 |
| Pubmed ID | |
| Authors |
J. Brent Richards, Alexandra Papaioannou, Jonathan D. Adachi, Lawrence Joseph, Heather E. Whitson, Jerilynn C. Prior, David Goltzman |
| Abstract |
Depression and osteoporotic fractures are common ailments among elderly persons. Selective serotonin reuptake inhibitors (SSRIs) are frequently used in the treatment of depression in this population, and the association between daily SSRI use and fragility fractures is unclear. Our objective was to examine the effect of daily SSRI use on the risk of incident clinical fragility fracture. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 1% |
| Spain | 2 | 1% |
| United Kingdom | 1 | <1% |
| India | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 129 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 19 | 14% |
| Researcher | 18 | 13% |
| Student > Master | 17 | 13% |
| Student > Bachelor | 9 | 7% |
| Student > Postgraduate | 9 | 7% |
| Other | 34 | 25% |
| Unknown | 30 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 43% |
| Psychology | 9 | 7% |
| Agricultural and Biological Sciences | 7 | 5% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Nursing and Health Professions | 4 | 3% |
| Other | 16 | 12% |
| Unknown | 36 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2022.
All research outputs
#1,225,049
of 25,373,627 outputs
Outputs from JAMA Internal Medicine
#3,457
of 11,639 outputs
Outputs of similar age
#3,171
of 172,060 outputs
Outputs of similar age from JAMA Internal Medicine
#13
of 59 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,639 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.9. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,060 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.